This Persistence Market Research (PMR) report examines the global scar treatment market for the period 2015 - 2024. The primary objective of the report is to offer insights into the developments in the scar treatment market that are moderately transforming the outlook of global businesses and enterprises in the related domain. Rising demand for laser treatments, primarily in view of shortening the treatment duration, is expected to bolster revenue growth of the scar treatment market over the next forecast years. In addition, increasing demand for tried and tested drugs and therapeutic combinations is expected to drive the growth of the global scar treatment market during the forecast period. Demand for scar treatments is primarily emerging from developed pharmaceutical markets such as Europe and North America, due to higher consumer affordability in these regions. However, emerging markets such as Brazil and UAE are fast catching up, owing to factors such as the boom in medical tourism and increasing demand for aesthetic corrective procedures in these regions.
The scar treatment market report begins with an overview of the scar treatment process and analysis of the various types of scars and their probable treatments. This section includes identifying the key features of scars and the respective considerations for appropriate commercial sizing of the market. The following section underlines factors influencing the growth of the scar treatment market currently, along with details of the key trends, drivers, restraints, opportunities, regulations, reimbursement scenarios, and an analysis of the impact expected to be created by each of the drivers and restraints over the forecast period. Impact analysis of the key regional growth drivers and restraints has been assessed based on the weighted average factor model along with key region-specific trends. This has been included in the market report to better equip clients with information and hidden insights. At the end of the report, PMR has included an exclusive section on the competitive landscape for players who plan to foray deeper into the existing market. The section highlights key upcoming requirements for companies to better capture higher market share and emerge profitable over the long term.
The global scar treatment market is analysed based on product type, scar type, end-user (distribution channel), and regions. Based on product type, the overall market has been segmented into topical products, laser products, surface treatment products, and injectable products. The topical product segment is further segmented into creams, gels, oils, and silicone gel sheets. The laser segment has been sub-segmented into CO2, excimer, and pulse-dyed lasers. Based on scar type, the market has been sub-segmented into atrophic scars, hypertrophic scars and keloids, contractures, and stretch marks. A detailed analysis of every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index, and BPS analysis has been provided along with the appropriate rationale for better understanding the market.
The next section of the report highlights the growth trends witnessed in the scar treatment market, by region. It provides a market outlook for 2015–2024 and sets the forecast within the context of the scar treatment market. The study discusses key regional trends contributing to the growth of the scar treatment market worldwide, as well as analyses the extent to which the corresponding drivers are influencing this market in each region, currently. Key regions assessed in this report include North America, Latin America, Europe, Asia-Pacific, and the MEA.
Analysis based on product-type, scar type, end-user (distribution channel), and region helps in evaluating the present scenario and growth prospects of the scar treatment market for the period 2015 –2024, in a holistic manner. We have considered 2014 as the base year and 2015 as the estimated year as some of the associated companies have not published their current financials.
To ascertain the scar treatment market size, we have also considered key parameters that should be considered while judging product uptake through various distribution channels. The forecast presented here assesses the total revenue generated, by value, across the scar treatment market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the scar treatment market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis, based on the supply side, downstream industry demand, and the economic envelope.
In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR but also analyse based on key parameters, such as Year-on-Year (Y-o-Y) growth rates, to understand the predictability of the market and to identify the right opportunities in the scar treatment market.
The scar treatment segments have been analysed in terms of the Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the scar treatment market.
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective, in the scar treatment market.
To understand key growth areas of scar treatment in the near future, Persistence Market Research developed the scar treatment market’s ‘Attractiveness Index’, which has been provided for all the four categories, namely product type, scar type, end users, and regions. The resulting index and related rationale are expected to help providers identify the real market opportunities.
In the final section of the report, competitive information related to the scar treatment market has been included to provide companies with insights required to enter or deepen revenue from a specific segment. This could help these companies in strengthening their revenue footprints in the scar treatment market and also to differentiate themselves. Key categories of providers covered in the report are scar treatment product manufacturers. Detailed company profiles have been primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a key market segment in the scar treatment value chain (provided in the market dynamics section). Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the scar treatment marketplace.
Detailed profiles of the providers also include company-specific long-term and short-term strategies, key offerings, and recent developments in the scar treatment market.
Key Segments Covered
By Product Type
By Scar Type
By End User/Distribution Channel
The global scar treatment market has been analyzed to gain an understanding about the changing landscape of the appearance and aesthetic corrective procedures. Scar revision is a procedure that is used to minimize the scars in a way that they appear more consistent with the surrounding skin tone and texture. Scars are visible signs that remain after a wound heals. They are unavoidable results of injury or surgery, and their development can be unpredictable. Scars may be raised or recessed, different in color or texture from the surrounding healthy tissue, or particularly noticeable due to their size, shape, or location. The market has been segmented by product type, scar type, end-users, and by geographical regions.
Market Value and Forecast
The global scar treatment market has been estimated to be valued at US$ 12,607.1 Mn by 2024 end, with various markets registering moderate CAGRs during the forecast period.
Growth in revenue generated from the sales of scar treatment products and services is directly attributed to the increasing economic growth and rising personal disposable income levels globally. While treatment of burn scars and keloids is considered to be medically necessary by regulatory bodies, treatment of spot correction, mild-to-medium acne is not deemed as a medical necessity. Rise in affluent population has also been responsible for further fuelling demand for aesthetic corrective procedures such as volume restoration, dermal filling, laser treatments, and wrinkle reduction. Hyaluronic acid based dermal fillers and botulinum type-A injections are prime examples of the same. Markets across the world are also witnessing growth in demand for combination therapeutics in scar treatments, with a view to increase effectiveness of the procedure and shorten treatment duration.
International regulatory benchmarking for uniform treatment guidelines and shortening of approval times are trends expected to prevail in the industry over the forecast period. This is expected to be accompanied with standardized documentation of clinical evidences of various combination therapeutics related to pharmacovigilance activities.
Market Segmentation, by Product Type
Based on product type, the overall market has been segmented into topical products, laser products, surface treatment products, and injectable products. The topical product segment is further sub-segmented into creams, gels, oils, and silicone gel sheets. The laser segment has been sub-segmented into CO2, excimer, and pulse-dyed lasers. Within the topical segment, the silicone gel products are expected to witness increased adoption. While silicone gel sheets could find increased application for treating hypertrophic scars and keloids, silicone gels could be used to treat acne. Brand positioning among reputed end-users is a typical marketing strategy being adopted by product manufacturers. Existing brand loyalty among physicians and pharmacists makes it difficult for new entrants to penetrate this market. In this regard, the ‘silicone gel sheet’ sub-segment has been estimated to be valued at US$ 2,443.8 Mn by the end of 2024, registering a moderate CAGR over the forecast period.
Market Segmentation, by Scar Type
Based on scar type, the market has been segmented into atrophic scars, hypertrophic scars and keloids, contractures, and stretch marks. Out of these four scar types, acne is the most common. Treatments for acne include a broad range of products, right from antibiotics to fractional CO2 lasers. Atrophic scar segment has been estimated to be valued at US$ 6,375.7 Mn by the end of 2024. Incidences of acne are estimated to increase over the forecast period due to changing lifestyles, increased consumption of frozen fatty food items, and early onset of ageing globally.
Market Segmentation, by End User
Based on end user, the global scar treatment market has been segmented into hospitals, clinics, pharmacies and retail drug stores, and e-commerce. Hospitals are clearly the most availed option by patients worldwide. However, treatment through specialist dermatologists at private clinics is a trend picking up in Brazil and Australia. The clinics segment is expected to be valued at US$ 3,840.4 Mn by 2024 end, registering a moderate CAGR over the forecast period.
The global scar treatment market has been segmented into five major regions, namely North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. In terms of value, North America market is estimated to be dominant, accounting for over one-third of the total scar treatment market value by 2015 end. Latin America is estimated to emerge as the fastest growing market among all the emerging regions, while revenue from the market in Europe is expected to expand at a healthy CAGR of 4.0% over the forecast period despite the ongoing economic downturn in the region. Over the forecast period, the growth in Europe is expected to be fuelled by the rapidly ageing population across all countries in the region.
Key companies covered in this report include Smith & Nephew PLC, Merz Inc., Enaltus LLC, Occulus Innovative Sciences Inc., CCA Industries Inc., Cynosure Inc, Avita Medical Limited, Lumenis, Syneron Medical Ltd., Nutramarks Inc., Mölnlycke Health Care, Pacific World Corporation, Valeant Pharmaceuticals International Inc., Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers), and Beijing Toplaser Technology Company Limited. The report is enriched through identification of company-specific strategies related to mergers and acquisitions, technological developments, product penetration strategies, sourcing, research and development, market consolidation initiatives, and analyses of the various market players’ specific strengths, weaknesses, opportunities, and threats.
Key competitors in the market, covered in terms of manufacturers, include: